Clinical trial
An Open-safety Study of the siCoV/KK46 Drug Administered Via an Inhaled Route in Healthy Volunteers
NCT05208996 is registered in ClinicalTrials.gov with National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-safety Study of the siCoV/KK46 Drug Administered Via an Inhaled Route in Healthy Volunteers
- Lead sponsor
- National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 22, 2021
- Completion date
- March 26, 2021
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.